335 related articles for article (PubMed ID: 7853416)
1. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin.
Pienta KJ; Naik H; Akhtar A; Yamazaki K; Replogle TS; Lehr J; Donat TL; Tait L; Hogan V; Raz A
J Natl Cancer Inst; 1995 Mar; 87(5):348-53. PubMed ID: 7853416
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin.
Nangia-Makker P; Hogan V; Honjo Y; Baccarini S; Tait L; Bresalier R; Raz A
J Natl Cancer Inst; 2002 Dec; 94(24):1854-62. PubMed ID: 12488479
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.
Powell CT; Gschwend JE; Fair WR; Brittis NJ; Stec D; Huryk R
Cancer Res; 1996 Sep; 56(18):4137-41. PubMed ID: 8797581
[TBL] [Abstract][Full Text] [Related]
4. Synergistic and additive effects of modified citrus pectin with two polybotanical compounds, in the suppression of invasive behavior of human breast and prostate cancer cells.
Jiang J; Eliaz I; Sliva D
Integr Cancer Ther; 2013 Mar; 12(2):145-52. PubMed ID: 22532035
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of dunning rat prostate tumor fluid on proliferation of the metastatic MAT-LyLu cell line.
Bugan I; Altun S
Asian Pac J Cancer Prev; 2015; 16(2):831-6. PubMed ID: 25684533
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
[TBL] [Abstract][Full Text] [Related]
8. In vitro characterization of MAT LyLu: a Dunning rat prostate adenocarcinoma tumor subline.
Wenger AS; Mickey DD; Hall M; Silverman LM; Mickey GH; Fried FA
J Urol; 1984 Jun; 131(6):1232-6. PubMed ID: 6539387
[TBL] [Abstract][Full Text] [Related]
9. Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells.
Haq M; Goltzman D; Tremblay G; Brodt P
Cancer Res; 1992 Sep; 52(17):4613-9. PubMed ID: 1511429
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
[TBL] [Abstract][Full Text] [Related]
11. Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions.
Inohara H; Raz A
Glycoconj J; 1994 Dec; 11(6):527-32. PubMed ID: 7696855
[TBL] [Abstract][Full Text] [Related]
12. Promotion of metastases by tumor necrosis factor in rats bearing Dunning R3327 MAT-LyLu prostatic cancer.
Iizumi T; Yazaki T; Umeda T; Soma GI
Urol Int; 1993; 51(2):85-8. PubMed ID: 8351760
[TBL] [Abstract][Full Text] [Related]
13. (-)-Gossypol reduces invasiveness in metastatic prostate cancer cells.
Huang YW; Wang LS; Dowd MK; Wan PJ; Lin YC
Anticancer Res; 2009 Jun; 29(6):2179-88. PubMed ID: 19528479
[TBL] [Abstract][Full Text] [Related]
14. The effect of castanospermine on the metastatic properties of prostate cancer cells.
Yee CS; Schwab ED; Lehr JE; Quigley M; Pienta KJ
Anticancer Res; 1997; 17(5A):3659-63. PubMed ID: 9413219
[TBL] [Abstract][Full Text] [Related]
15. Dimethylsulfoxide-induced changes in a rat prostate adenocarcinoma.
Wenger AS; Hall M; Mickey GH; Silverman L; Fried FA; Mickey DD
Prostate; 1985; 6(4):329-41. PubMed ID: 4088948
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF-κB activation and recurrent dexamethasone administration fails to suppress it in vivo.
Jain S; Dash P; Minz AP; Satpathi S; Samal AG; Behera PK; Satpathi PS; Senapati S
Prostate; 2019 Feb; 79(2):168-182. PubMed ID: 30264470
[TBL] [Abstract][Full Text] [Related]
17. In vivo antitumor activity of bropirimine against PAIII and Dunning MAT-LyLu rodent prostate cancers.
Sarosdy MF; Higdon AL; Demoor CA
J Urol; 1996 Jun; 155(6):2085-9. PubMed ID: 8618341
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model.
Liu HY; Huang ZL; Yang GH; Lu WQ; Yu NR
World J Gastroenterol; 2008 Dec; 14(48):7386-91. PubMed ID: 19109874
[TBL] [Abstract][Full Text] [Related]
19. Modified citrus pectin-monograph.
Altern Med Rev; 2000 Dec; 5(6):573-5. PubMed ID: 11134980
[TBL] [Abstract][Full Text] [Related]
20. Differences in expression of oligosaccharide determinants by phenotypically distinct sublines of the Dunning 3327 rat prostate cancer.
Abel PD; Foster CS; Tebbutt S; Williams G
J Urol; 1990 Sep; 144(3):760-5. PubMed ID: 2388349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
